Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement Trial results cons ...

Dementia poses an increasing global health challenge, and the introduction of new drugs with diverse activity profiles ...